Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors.
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.
Alexithymia in Neurological Disease: A Review.
Burden of risk variants correlates with phenotype of multiple sclerosis.
The relationship between cognitive function and high-resolution diffusion tensor MRI of the cingulum bundle in multiple sclerosis.
Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab.
Alterations of juxtaparanodal domains in two rodent models of CNS demyelination.
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes.
TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation.
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
What is the true clinicopathologic spectrum of neuromyelitis optica?-Reply.
Ambulation and multiple sclerosis.
Verbal fluency deficits in clinically isolated syndrome suggestive of multiple sclerosis.
Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis.
Multiple sclerosis: Activation of cortical microglia linked to level of disability in patients with multiple sclerosis.
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice.
Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function.
Currently Approved And Emerging Oral Therapies In Multiple Sclerosis: An Update For The Ophthalmologist.
Acute inflammatory myelopathies.
TREK-King the Blood-Brain-Barrier.
Cognitive and brain reserve for mind-body therapeutic approaches in multiple sclerosis: A review.
Epstein-Barr virus in multiple sclerosis.
Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.

Pages